E
RXST icon

Ergoteles’s RxSight RXST Stock Holding History

Ergoteles’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-24,293
Closed -$273K – 1584
2021
Q4 		$273K Buy
+24,293
New +$292K 0.01% 897

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Ergoteles's RXST Position: Q1 2022 in Review

Ergoteles sold out of RxSight (RXST) in Q1 2022, closing a stake of 24,293 shares — an estimated $273K sold.

Ergoteles first reported a position in RXST in Q4 2021 and held it in 1 quarter. The position peaked at $273K in Q4 2021. 45 funds tracked by Wall St. Rank hold RXST as of Q1 2022.

  • Ergoteles reported no remaining RxSight position as of Q1 2022 after selling out during the quarter.
  • Ergoteles sold 24,293 RxSight shares in Q1 2022, an estimated $273K.
  • Ergoteles first reported a position in RxSight in Q4 2021 and held it in 1 quarter.
  • Ergoteles's RxSight position peaked at $273K in Q4 2021.
  • 45 funds tracked by Wall St. Rank held RxSight as of Q1 2022.

Based on Ergoteles's 13F filing for Q1 2022, filed 13 May 2022.